Dr. Tali Kizhner has over 15 years of diverse R&D and CMC industrial experience in the development of therapeutic proteins and dietary supplements.
Tali joined Nurexone from Biond Biologics, bringing high edge expertise in intracellular delivery of biologics. Her position of R&D Director in International Fragrance and Flavors (IFF) included leading local and global activities in the field of dietary supplements and functional foods. Prior to IFF, at Protalix Biotherapeutics Tali played a pivotal role in research and development of several biologics, including approved by EMEA and FDA pegunigalsidase alfa for Fabry disease.
Tali holds a Ph.D. in Biotechnology and Food Engineering from the Technion – Israel Institute of Technology, with postdoctoral specialization in mesenchymal progenitor cells.
